THE LEVEL OF IMMUNE CHECKPOINT CO-INHIBITORS IN TUMOR TISSUE IN PATIENTS WITH COLON TUMOR

Author:

Abstract

Introduction. A high level of checkpoint co-inhibitors in the tumor microenvironment plays an important role in inhibiting the local immune response, which contributes to the growth and progression of cancer. The aim of the study. We aimed to determine immune checkpoint co-inhibitors level (CTLA-4, TIM-3, LAG-3, PD-1) and their ligands (B7-2, Galectin-9, PD-L1) in tumor tissue in patients with benign tumor of the colon and cancer. Methods: the study enrolled 94 patients divided into 3 groups: 44 patients with colorectal cancer, 25 with a benign colon tumor, 25 – a control group (patients who underwent plastic surgery of a colostomy formed earlier due to a colon injury). The level of immune checkpoint co-inhibitors and their ligands was studied in tumor tissue by flow cytofluometry on a CytoFlex LX analyzer (Beckman Coulter, USA) using the LEGENDplex ™ HU multiplex analysis kit (Immune Checkpoint, USA) Results: we found that in patients with colon cancer the level of immune checkpoint co-inhibitors (TIM-3, CTLA-4, LAG-3) in the homogenate supernatant of the tumor tissue was higher than in the control group. The level of TIM-3 protein increased by 43.6 times (p 0.001), CTLA-4 – by 2.3 times (p=0.007), LAG-3 – by 5.1 times (p 0.001). Patients with colorectal cancer also showed the elevation of the concentration of TIM-3 protein by 11.4 times (p <0.001), LAG-3 by 1.8 times (p=0.008), CTLA-4 protein by 1.5 times (p=0.02) compared to patients with benign colon tumor. In patients with colorectal cancer, the level of the TIM-3 ligand (Galectin-9) exceeded the indicator of the control group by 56.7 times (p <0.001), and the CTLA-4 ligand (B7-2) – by 1.7 times (p=0.004). In addition, the concentration of Galectin-9 in patients with CRC was 3.4 times higher (p<0.001), the B7-2 ligand was 1.5 times higher (p=0.04). compared to patients with benign colon tumor. Conclusion: an increase in the level of CTLA-4, TIM-3, LAG-3 and their ligands – B7-2 and Galectin-9 in tumor tissue indicates the involvement of these molecules in the cancer genesis of colorectal cancer.

Publisher

Russian Vrach, Publishing House Ltd.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3